Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Fecal Microbiota Transplantation for Ulcerative Colitis.

ABSTRACT: Fecal Microbiota Transplantation for Ulcerative Colitis.

PROVIDER: PRJEB46777 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR6406250_1.fastq.gz	Fastqsanger.gz
	ERR6406250_2.fastq.gz	Fastqsanger.gz
	ERR6406260_1.fastq.gz	Fastqsanger.gz
	ERR6406260_2.fastq.gz	Fastqsanger.gz
	ERR6406270_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 267

Similar Datasets

Fecal Microbiota Transplantation for Ulcerative Colitis and C. difficile Infection.

Project description:Fecal Microbiota Transplantation for Ulcerative Colitis and C. difficile Infection.

| PRJEB46780 | ENA

OTUD3 prevents ulcerative colitis by modulating microbiota-mediated STING activation (part 3)

Project description:Ulcerative colitis (UC) develops through a complicated interaction between the host and microbiota. Intestinal fibroblasts are suggested to play crucial roles in the pathogenesis of UC. However, the influences of the host-microbiota interaction on the pathophysiology of intestinal fibroblasts remain poorly understood. Here, we reveal that OTUD3 suppresses pathologic activation of fibroblasts exposed to microbial cyclic GMP-AMP (3’3’-cGAMP) by deubiquitinating stimulator of interferon genes (STING) in the colon. Sting deficiency ameliorated dextran sodium sulfate-induced colitis in Otud3-/- mice. In addition, mice harboring an UC risk missense variant in the Otud3 gene showed pathological features of UC in the colon after transplantation of a fecal microbiome with the potential to produce excessive cGAMP from UC patients. Collectively, these results demonstrate the critical role of OTUD3 in the maintenance of intestinal homeostasis and highlight one mechanism of the interaction between the host (OTUD3 in fibroblasts) and microbiota (STING agonist) in UC development.

2025-05-12 | GSE244078 | GEO

OTUD3 prevents ulcerative colitis by modulating microbiota-mediated STING activation (part 2)

2025-05-12 | GSE244077 | GEO

OTUD3 prevents ulcerative colitis by modulating microbiota-mediated STING activation (part 1)

2025-05-12 | GSE244076 | GEO

OTUD3 prevents ulcerative colitis by modulating microbiota-mediated STING activation (part 5)

2025-05-12 | GSE244080 | GEO

OTUD3 prevents ulcerative colitis by modulating microbiota-mediated STING activation (part 4)

2025-05-12 | GSE244079 | GEO

Fecal Microbiota Transplantation for refractory immune checkpoint inhibitor-associated colitis

Project description:We report the first case series of ICI associated colitis successfully treated with fecal microbiota transplantation (FMT), with reconstitution of the gut microbiome and a relative increase in the proportion of regulatory T cells (Tregs) within the colonic mucosa. These preliminary data provide evidence that modulation of the gut microbiome may abrogate ICI-associated colitis.

| EGAS00001003217 | EGA

16S rRNA Sequences from Pediatric Ulcerative Colitis Patients Before and After Fecal Microbiota Transplantation

Project description:Gut microbial and metabolomic profiles after fecal microbiota transplantation in pediatric ulcerative colitis patients

| PRJEB25560 | ENA

Ulcerative Colitis Fecal Transplant Metaproteomic Study

Project description:Ulcerative Colitis fecal samples were transplanted into IL10 deficient gnotobiotic mice. Half of the mice received a protease inhibitor cocktail in their drinking water. After 8-weeks colonization the animals were studied for colonic inflammation, and fecal samples were collected and analyzed by LC-MS3 based quantitative metaproteomics. Data from mice transplanted with two UC patients were analyzed in this dataset.

2020-11-23 | MSV000086510 | MassIVE

Impact of fecal microbiota transplantation (FMT) in 3 days-ABX-treated recipient mice using feces from 6 NSCLC patients at diagnosis.

Project description:This study aimed to analyze changes in gut microbiota composition in mice after transplantation of fecal microbiota (FMT, N = 6) from the feces of NSCLC patients by analyzing fecal content using 16S rRNA sequencing, 10 days after transplantation. Specific-pathogen-free (SPF) mice were used for each experiments (N=4) as controls.

2023-07-01 | E-MTAB-12812 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data